Menu
ncarol.com
  • Home
  • Health
  • Real Estate
  • Non-profit
  • Financial
  • Transportation
  • Arts
  • Business
  • Services
ncarol.com

New Study Reveals Alarming Cardiac Risks Associated with Electroshock Treatment
ncarol.com/10274175

Trending...
  • PebblePad Announces Global Partnership with Inside Higher Ed and Times Higher Education
  • Powering the Next Frontier of the $1 Trillion Space Economy: Ascent Solar Technologies (N A S D A Q: ASTI)
  • Dr. Jay A. Johannigman Delivers Lecture at the John R. Border Memorial Lectureship in Buffalo
Study Reveals Cardiac Risks Associated with ECT
The mental health industry watchdog, CCHR, says informed consent is breached every time patients are not warned of the brain damage, long-term memory loss, and cardiac risks, including death, associated with electroshock, per the study.

LOS ANGELES - ncarol.com -- A new study has determined that as many as 1 in 15 people who receive electroshock treatment face life-threatening heart problems, which can lead to death. John Read, Ph.D., a Professor of Psychology at the University College of London critiqued studies of electroconvulsive therapy (ECT) and cited a 2019 review that he says misrepresented data and falsely asserted that ECT is safe. In reality, cardiac events are the leading cause of death for those subjected to shock treatment.[1] The Citizens Commission on Human Rights International, a mental health industry watchdog, says this critical information must be transparently communicated to patients recommended for ECT, including the risks of permanent brain damage and memory loss. According to Dr. Read's study, "the ethical principle of informed consent is being routinely breached by ECT psychiatrists."

Jan Eastgate, President of CCHR International, says that for decades there has been a cover-up of the seriousness of the effects of ECT, which sends up to 460 volts of electricity through the brain, causing a grand mal seizure. "Electroshock has no place in mental health treatment and should be banned," she said, adding, "Given without a patient's consent is internationally recognized as constituting torture."

According to U.S. expert, Ken Castleman, a biomedical engineer, "ECT stimulates the sympathetic nervous system, which controls many aspects of cardiovascular function. The powerful electrical discharge causes a spike in blood pressure. The intense stress that the ECT-induced seizure places on the heart increases the risk of adverse cardiovascular events, especially in patients who have pre-existing cardiac conditions."

More on ncarol.com
  • $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
  • Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
  • Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
  • 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
  • uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals

Dr. Read reports, "The obligation to ensure informed consent is a core ethical principle of all health and mental health professionals." Yet, "Various official reports, most psychiatric textbooks, and many patient information leaflets have claimed, for decades, that the risk of death from ECT is so rare as to be inconsequential," including an American Psychiatric Association (APA) ECT Task Force Report on ECT. "It should be noted that six of the eight task force members were directors of ECT services." The group included three members who were financially involved with companies manufacturing ECT machines, Dr. Read wrote.

Citing the 2023 joint guidance by the World Health Organization/United Nations, Dr. Read continued: "People being offered ECT should be made aware of all its risks and potential short- and long-term harmful effects, such as memory loss and brain damage. ECT is not recommended for children, and this should be prohibited through legislation."

The study further discusses the death rate:
  • Of 8,148 ECT recipients in Texas, seven died within 2 days of their last ECT. Even excluding the two that the researchers believed were "unlikely to have been related to ECT," this is a "rate of 1 per 1,630 people. If one includes the additional eight that died, from 'cardiac events' in the following 12 days, the rate is 1 per 627."
  • A 2019 review of 43 ECT studies with mortality data, including more than 75,000 patients, calculated, "All-cause mortality was 0.42 deaths per 1,000 patients." This is 1 per 2,380 people, more than four times greater than the official position of the APA of 1 per 10,000.
  • A 2023 Swedish register-based study was comprehensive in finding that of 20,225 ECT patients, 123 (0.61%) died of "medical causes" within 30 days of their last ECT—one death per 164 people. At one per 413 patients, the 49 cardiac-related deaths represented the most common medical cause of post-ECT death (40%). This was surpassed only by the 93 suicides (1 per 217).  In total, 15 of the 23 patients who died within 24 hours of ECT were cardiovascular deaths.
As Dr. Read points out, in 2001, the APA acknowledged that "evidence has shown that ECT can result in persistent or permanent memory loss." In 2018, an ECT device manufacturer included "permanent brain damage" in its list of risks, yet this information was not being forwarded to patients.

More on ncarol.com
  • Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
  • Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
  • BillyGoat Mulching Introduces Advanced Subsoil Mulching for Premium Land Finishing and Development
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion

In the U.S., adolescents and even children five years old and younger have been electroshocked. Dr. Read found "rates of memory deficits in more than two-thirds of child and adolescent ECT patients" that were passed off as "acceptable" and misrepresented as a "high level of safety." Dr. Read wrote to the journal stating: "The use of sufficient electricity, once, on a developing brain, in order to cause a seizure in that young brain, is a very serious matter. To do so five or six times in a few weeks is almost bound to cause brain damage in a significant number of recipients. The average age of these youngsters was just 15.5 years. Most (62 %) were girls. When even the psychiatrists themselves acknowledge that 69 % have impaired memories as a result, this does not indicate a treatment with a 'high' degree of safety."

The main cardiac events Dr. Read found are myocardial infarction (heart attack), life-threatening arrhythmia (irregular heartbeat), acute pulmonary edema (fluid on the lungs), pulmonary embolism (blood clots), acute heart failure, and cardiac arrest.

In light of these grave risks, CCHR welcomes the recent news that electroshock is nearly on the brink of disappearing due to public awareness campaigns, including CCHR's documentary, Electroshock: Therapy or Torture. "It's an incredible story that goes back decades," says Harold Sackeim, a psychologist and major proponent of ECT, who is worried that exposure of ECT could be "successful at killing an industry."

Ms. Eastgate responds, "It is far better that the multi-billion-dollar electroshock industry be killed off rather than its patients. Their safety must be the priority. The current study and many others reflect the ongoing concerns that ECT should be banned."

About CCHR: Established in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz, CCHR has secured state bans of ECT use on minors. It also had Deep Sleep Treatment (DST), which includes ECT, banned in Australia, which last year the WHO said should be prohibited worldwide.

Source:

[1] Read, J. 2024. Major adverse cardiac events and mortality associated with electroconvulsive therapy: Correcting and updating a 2019 meta-analysis. Ethical Human Psychology and Psychiatry, repository.uel.ac.uk/item/8xyx0

Contact
Citizens Commission on Human Rights
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Veterans Day 2025: Honoring Service Through Storytelling
  • Kaltra Offers Microchannel Condensers Optimized for Low-GWP Refrigerants R454B, R32, and R290
  • Putting Your Roses to Bed for Winter in the Deep South - A Gentleman's Guide to Fall Rose Care
  • Tens of Thousands Complete Course to Master Entire Bible, Including Revelation
  • UK Financial Ltd Unveils The First ERC-3643 Security Token Born from a Meme: Introducing MayaCat Regulated Security Token (SMCAT) Successor to MayaCat
  • Kaplan Morrell Law Firm Represents Former NHL Player in Workers' Compensation Case Drawing National Attention
  • Local Lighting Experts Debut AI Christmas Decorator: Upload a Photo, Get Instant Professional Holiday Design-- Completely Free
  • Surf Air Mobility (N Y S E: SRFM) Accelerates Regional Air Mobility Revolution with Electra Aero Partnership, Palantir Alliance, and Record Revenue
  • Cybersecurity is Fast Becoming a Vital Issue for Protecting Personal Information and Portfolio Wealth
  • 10 Essential Tips for Maximizing Value When Choosing Your Orlando Wedding Venue
  • Americans Are Trading Offices for Beaches: How Business Ownership Enables the Ultimate Location Freedom
  • Learn "The Art of Giving" at the Hillsborough Gallery of Arts
  • Boston Industrial Solutions' Natron® DC Series Ink Has Had an Upgrade!
  • Colony Ridge Proudly Supports the All Ears! 2025 Sporting Clays Tournament
  • Make Your Own Perfume Party Kit
  • Jacob Emrani Nominated for LA Executive Award
  • Advanced Roofing and Exteriors Named Builders Mutual 2025 WorkSafe Champion
  • Natural Perfume Formulas By JoAnne Bassett For Sale
  • Kansas City Steak Company Shares the Return of Their Holiday Gift Box
  • Dr. Jay A. Johannigman Delivers Lecture at the John R. Border Memorial Lectureship in Buffalo
_catLbl0 _catLbl1

Popular on ncarol.com

  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation - 152
  • Heritage at South Brunswick's Townhome Models Coming Soon! - 145
  • Arc Longevity Sells Out Debut Women's Creatine Gummy - 142
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG) - 136
  • $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST - 134
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer - 133
  • Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses - 132
  • Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching? - 130
  • Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida - 127
  • New Free Educational Bingo Cards Make Learning English Fun for First Graders - 125

Similar on ncarol.com

  • Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute